CLSA Op-Ed in Xconomy: California Life Sciences Fueled by Education, Established Companies
New medicines, devices, and diagnostics produced by the life sciences community in California are giving clinicians better tools to fight disease and improve quality of life for patients around the world. CLSA President & CEO Mike Guerra pens an op-ed in Xconomy on the strength and growth of California’s life sciences sector.
New Legislator Spotlight: State Senator Bob Archuleta (D-Pico Rivera)
May 16, 2019 In each issue of our CLSA Bulletin, we will highlight a member of California’s ten-member “freshman class” in the California State Senate. On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes Senator Bob Archuleta (D-Pico … Continue reading New Legislator Spotlight: State Senator Bob Archuleta (D-Pico Rivera)
CLSA Board of Directors Engages Lawmakers in Washington, D.C.
On Wednesday, May 8, 15 members of CLSA’s Board of Directors spent a full day on Capitol Hill meeting with nearly 20 key legislators and senior staff, on issues of importance to California’s biomedical innovation ecosystem.
Governor Newsom Releases His Revised Budget Plan
On May 9, 2019, Governor Newsom released a revised state budget proposal (known as the “May Revise”) focusing on health care, housing, early childhood, and education. The budget addressed his priorities for the “Healthcare for All” policy agenda, which includes expanding Medi-Cal coverage to young adults regardless of their immigration status.
CLSA Helps Lead the Charge to Defeat Two Bills Restricting Research and Education Using Animals
Two bills sponsored by the organizations Physicians Committee for Responsible Medicine and Social Compassion in Legislation were defeated by CLSA and fellow research and education-focused stakeholders in recent weeks.
CLSA & Allied Stakeholders Succeed in Reversing Administration’s Final Rule on Six Protected Classes in Medicare Part D
On Thursday, May 16, CLSA’s advocacy paid off when CMS released its final rule and fact sheet. In the final rule, CMS decided to not adopt two proposals which would have allowed Part D plans to exclude a protected class drug from their formularies for multiple years if price-growth exceeded an inflation index as well as if the drug represented a new formulation that is not a significant innovation over the original product.
New Legislator Spotlight: Assemblymember Rebecca Bauer-Kahan (D-Orinda)
On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes Assemblymember Rebecca Bauer-Kahan. We look forward to working with Assemblymember Bauer-Kahan and her team to advance policies that improve patient health and bring positive change for California patients and their families.
Stage IV Colon Cancer Patient Advocate Delivers Powerful Keynote at CLSA’s Annual Spring Dinner
On Tuesday, May 7, CLSA hosted its annual Spring Reception and Dinner at the Folger Shakespeare Library on Capitol Hill to recognize and welcome the seven freshman members of the California Congressional Delegation.
CLSA Executive Profile in Global Business Reports: An Interview with Mike Guerra, California Life Sciences Association (CLSA)
CLSA President & CEO Mike Guerra recently sat down with Global Business Reports to discuss CLSA’s mission, as well as the commitment of our members in helping patients, while boosting investment, innovation and job creation in California’s life sciences sector.
New Legislator Spotlight: Congresswoman Katie Hill (D-Agua Dulce)
On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes Congresswoman Katie Hill (D-Agua Dulce). We look forward to working with Congresswoman Hill and her team to advance policies that improve patient health and bring positive change for California patients and their families.